December 19, 2023 10:26 AM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Ver­tex, CRISPR get un­in­tend­ed role in SNL skit; Re­al Chem­istry and can­cer so­ci­ety de­but AI ef­fort

Beth Snyder Bulik

Senior Editor

NBC’s late night show “Sat­ur­day Night Live” is no stranger to pok­ing fun at the phar­ma in­dus­try, es­pe­cial­ly its ad­ver­tis­ing. How­ev­er, the lat­est SNL bio­phar­ma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times